Dr. A. Sofia Cerdeira
Contact information
+44 (0)1865 221021
Colleges
Collaborators
-
Manu Vatish
Professor of Obstetrics & Consultant Obstetrician
Honours and Awards
- MFM Fellowship - 2022
- MRCOG membership - 2021
- CRN TVSM Fellowship - 2021
- HIMSS FUTURE50-Europe Class 2019
- L'Oreal-Unesco For Women in Science Award - High Commendation - 2019
- UNIVANTS of Healthcare Excellence Award - 2019
- Canon Fellowship, Canon Foundation in Europe - 2019
- HSJ Healthcare Partnership Award - 2019
- Africa Oxford Initiative Travel Grant, University of Oxford - 2018
- NIHR Academic Clinical Lectureship - 2017
- Junior Research Fellowship, Somerville College, University of Oxford - 2015
- NIHR Academic Clinical Fellowship - 2014
- Vision Grant Award, Preeclampsia Foundation, USA - 2013
- Best Data Club presentation of the year award - CVBR - Harvard University - 2012
- Excellence in Tutoring Award - Physiology, Harvard Medical School - 2012
A. Sofia Cerdeira
MD PhD
NIHR Academic Clinical Lecturer
- Lecturer in Medicine Somerville College Oxford
- MFM Fellow Queen Charlotte's and Chelsea Hospital
Research groups
L'Oreal-Unesco For Women in Science finalists
HSJ Healthcare Partnership Award
Key publications
Randomized Interventional Study on Prediction of Preeclampsia/Eclampsia in Women With Suspected Preeclampsia: INSPIRE.
Journal article
Cerdeira AS. et al, (2019), Hypertension, 74, 983 - 990
Recent publications
cute Presentation of Nonpuerperal Uterine Inversion Following a Diagnosis of Uterine Carcinosarcoma: A Case Report
Journal article
More AK. et al, (2026), Clinical Case Reports, 14
Predictive accuracy of sFlt-1/PlGF ratio for preeclampsia and adverse outcomes: prospective, multicenter including primary, secondary, and tertiary care institutions, observational study in Japan.
Journal article
Yamazaki T. et al, (2025), Hypertens Res, 48, 2548 - 2557
Considerations for gestational age, delivery indication, and therapies in preeclampsia prediction.
Journal article
Palma Dos Reis CR. et al, (2025), Am J Obstet Gynecol, 233
The ratio of soluble fms-like tyrosine kinase 1 to placental growth factor predicts time to delivery and mode of birth in patients with suspected preeclampsia: a secondary analysis of the INSPIRE trial.
Journal article
Palma Dos Reis CR. et al, (2025), Am J Obstet Gynecol, 232, 317.e1 - 317.e17
FGFR2 Genetic Variant C.1019A > G p.(Tyr340Cys) in a Fetus with Pfeiffer Type II Syndrome Diagnosed by a Combination of 3D Ultrasound Phenotyping and DNA Sequencing
Journal article
Scalia MS. et al, (2025), Journal of Fetal Medicine, 12, 032 - 034
research
Pre-eclampsia, angiogenic factors
I am a clinician scientist with a particular interest in pre-eclampsia and angiogenic factors. We recently conducted the first clinical trial on the use of sFlt-1/PlGF ratio in the management of patients with suspected pre-eclampsia (Cerdeira AS et al. Hypertension 2019). Data from our study and previous observations lead to the development of a protocol that is now used in clinical practice. My aim is to continue exploring the role of angiogenic factors in the prediction, diagnosis and treatment of pre-eclampsia, hopefully leading to meaningful changes in patient care.
news featuring:
https://www.ox.ac.uk/research/research-impact/life-saving-test-preeclampsia
https://www.thetimes.co.uk/article/new-blood-test-takes-doubt-out-of-pre-eclampsia-pp5mmv30p
https://www.bbc.co.uk/news/health-60860826
https://www.ouh.nhs.uk/news/article.aspx?id=1058